Serological and cellular inflammatory signatures in end‐stage kidney disease and latent tuberculosis
Abstract Objectives Tuberculosis comorbidity with chronic diseases including diabetes, HIV and chronic kidney disease is of rising concern. In particular, latent tuberculosis infection (LTBI) comorbidity with end‐stage kidney disease (ESKD) is associated with up to 52.5‐fold increased risk of TB rea...
Enregistré dans:
Auteurs principaux: | Milla R McLean, Kathleen M Wragg, Ester Lopez, Sandra A Kiazyk, Terry Blake Ball, Joe Bueti, Stephen J Kent, Jennifer A Juno, Amy W Chung |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/76cfc55d07b34fe8b4af19c8ed672243 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Bone Marrow Hypocellularity in Patients with End-Stage Kidney Disease
par: Chia-Chen Hsieh, et autres
Publié: (2021) -
Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects
par: Nenova-Nogalcheva A., et autres
Publié: (2020) -
Urgent-start peritoneal dialysis for end-stage renal disease patients: literature review and worldwide evidence-based practice
par: Atthaphong Phongphithakchai, et autres
Publié: (2021) -
Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
par: Semen V. Nesterov, et autres
Publié: (2018) -
Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis
par: Dezhi Yuan, et autres
Publié: (2021)